6FFA | pdb_00006ffa

FMDV Leader protease bound to substrate ISG15


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free: 
    0.186 (Depositor), 0.187 (DCC) 
  • R-Value Work: 
    0.165 (Depositor), 0.169 (DCC) 
  • R-Value Observed: 
    0.166 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6FFA

This is version 1.4 of the entry. See complete history

Literature

Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies.

Swatek, K.N.Aumayr, M.Pruneda, J.N.Visser, L.J.Berryman, S.Kueck, A.F.Geurink, P.P.Ovaa, H.van Kuppeveld, F.J.M.Tuthill, T.J.Skern, T.Komander, D.

(2018) Proc Natl Acad Sci U S A 115: 2371-2376

  • DOI: https://doi.org/10.1073/pnas.1710617115
  • Primary Citation Related Structures: 
    6FFA

  • PubMed Abstract: 

    In response to viral infection, cells mount a potent inflammatory response that relies on ISG15 and ubiquitin posttranslational modifications. Many viruses use deubiquitinases and deISGylases that reverse these modifications and antagonize host signaling processes. We here reveal that the leader protease, Lb pro , from foot-and-mouth disease virus (FMDV) targets ISG15 and to a lesser extent, ubiquitin in an unprecedented manner. Unlike canonical deISGylases that hydrolyze the isopeptide linkage after the C-terminal GlyGly motif, Lb pro cleaves the peptide bond preceding the GlyGly motif. Consequently, the GlyGly dipeptide remains attached to the substrate Lys, and cleaved ISG15 is rendered incompetent for reconjugation. A crystal structure of Lb pro bound to an engineered ISG15 suicide probe revealed the molecular basis for ISG15 proteolysis. Importantly, anti-GlyGly antibodies, developed for ubiquitin proteomics, are able to detect Lb pro cleavage products during viral infection. This opens avenues for infection detection of FMDV based on an immutable, host-derived epitope.


  • Organizational Affiliation
    • Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom.

Macromolecule Content 

  • Total Structure Weight: 28.61 kDa 
  • Atom Count: 2,142 
  • Modeled Residue Count: 234 
  • Deposited Residue Count: 245 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Lbpro167Foot-and-mouth disease virusMutation(s): 0 
UniProt
Find proteins for P03305 (Foot-and-mouth disease virus serotype O)
Explore P03305 
Go to UniProtKB:  P03305
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP03305
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Ubiquitin-like protein ISG1578Homo sapiensMutation(s): 1 
Gene Names: ISG15G1P2UCRP
UniProt & NIH Common Fund Data Resources
Find proteins for P05161 (Homo sapiens)
Explore P05161 
Go to UniProtKB:  P05161
PHAROS:  P05161
GTEx:  ENSG00000187608 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP05161
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
SO4

Query on SO4



Download:Ideal Coordinates CCD File
G [auth A],
H [auth A],
I [auth A]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
GOL

Query on GOL



Download:Ideal Coordinates CCD File
C [auth A],
D [auth A],
E [auth A],
F [auth A],
J [auth B]
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free:  0.186 (Depositor), 0.187 (DCC) 
  • R-Value Work:  0.165 (Depositor), 0.169 (DCC) 
  • R-Value Observed: 0.166 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 114.188α = 90
b = 40.352β = 91.81
c = 58.052γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Medical Research Council (United Kingdom)United KingdomU105192732
European Research CouncilUnited Kingdom309756
European Research CouncilUnited Kingdom724804
Lister Institute for Preventative MedicineUnited Kingdom--

Revision History  (Full details and data files)

  • Version 1.0: 2018-02-21
    Type: Initial release
  • Version 1.1: 2018-03-07
    Changes: Database references
  • Version 1.2: 2018-03-14
    Changes: Database references
  • Version 1.3: 2024-01-17
    Changes: Data collection, Database references, Refinement description
  • Version 1.4: 2024-10-16
    Changes: Derived calculations, Structure summary